malondialdehyde has been researched along with daphnetin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Liu, TY; Liu, ZY; Shi, Q; Wang, LK; Wang, WX; Zhao, KL; Zhao, L; Zuo, T | 1 |
| Bu, H; Guo, L; Wang, H; Xu, K | 1 |
| Deng, Q; Li, Y; Wu, L; Zou, L | 1 |
3 other study(ies) available for malondialdehyde and daphnetin
| Article | Year |
|---|---|
Protective effects of daphnetin on sodium taurocholate‑induced severe acute pancreatitis in rats.
Topics: Amylases; Animals; Cytokines; Disease Models, Animal; Inflammation Mediators; Lipase; Male; Malondialdehyde; Pancreatitis; Peroxidase; Protective Agents; Rats; Taurocholic Acid; Umbelliferones | 2014 |
Daphnetin inhibits high glucose-induced extracellular matrix accumulation, oxidative stress and inflammation in human glomerular mesangial cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Cell Proliferation; Cells, Cultured; Cytokines; Diabetic Nephropathies; Extracellular Matrix; Glucose; Humans; Malondialdehyde; Mesangial Cells; Reactive Oxygen Species; Superoxide Dismutase; Umbelliferones | 2019 |
Chemoprotective Effect of Daphnetin in Doxorubicin Treated Esophageal Cancer Stem Cell Xenograft Tumor Mouse.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Doxorubicin; Esophageal Neoplasms; Humans; Male; Malondialdehyde; Mice; Mice, Nude; Neoplastic Stem Cells; Oxidative Stress; Umbelliferones | 2021 |